Katrine Bosley
According to Genocea Biosciences’ CEO, the appointment of Katrine Bosley “brings a unique and important perspective” to the company’s Board of Directors.
Katrine was the CEO of Avila Therapeutics and will join the T-Cell vaccine clinical stage company as an Independent Director.